United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | 984,800 | 727,300 | 475,800 | 514,800 | -104,500 |
Depreciation Amortization | 53,200 | 51,300 | 49,900 | 49,900 | 45,900 |
Accounts receivable | -58,500 | -21,700 | -41,300 | -6,000 | 24,400 |
Accounts payable and accrued liabilities | 57,100 | 44,500 | -12,500 | 38,600 | -16,300 |
Other Working Capital | -97,800 | -141,200 | -174,200 | 63,100 | -178,300 |
Other Operating Activity | 39,200 | 142,300 | 300,500 | 95,300 | 22,200 |
Operating Cash Flow | $978,000 | $802,500 | $598,200 | $755,700 | $-206,600 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -2,514,300 | -1,706,300 | -1,736,200 | -2,205,000 | -1,038,400 |
PPE Investments | -230,400 | -138,800 | -120,800 | -56,900 | -83,700 |
Net Acquisitions | -89,200 | N/A | N/A | N/A | N/A |
Purchase Of Investment | -23,000 | 0 | 0 | N/A | N/A |
Sale Of Investment | 2,137,300 | 1,030,100 | 1,370,100 | 1,523,400 | 799,200 |
Other Investing Activity | 0 | 3,500 | 0 | 0 | -12,500 |
Investing Cash Flow | $-719,600 | $-811,500 | $-486,900 | $-738,500 | $-335,400 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 0 | 800,000 | 0 | 0 | 800,000 |
Common Stock Issued | 104,600 | 94,300 | 55,600 | 38,500 | 14,000 |
Common Stock Repurchased | -13,800 | -11,400 | -10,800 | -3,700 | -2,100 |
Other Financing Activity | -102,700 | -807,500 | 0 | -51,700 | -200,700 |
Financing Cash Flow | $-11,900 | $75,400 | $44,800 | $-16,900 | $611,200 |
Beginning Cash Position | 961,200 | 894,800 | 738,700 | 738,400 | 669,200 |
End Cash Position | 1,207,700 | 961,200 | 894,800 | 738,700 | 738,400 |
Net Cash Flow | $246,500 | $66,400 | $156,100 | $300 | $69,200 |
Free Cash Flow | |||||
Operating Cash Flow | 978,000 | 802,500 | 598,200 | 755,700 | -206,600 |
Capital Expenditure | -230,400 | -138,800 | -120,800 | -59,300 | -83,700 |
Free Cash Flow | 747,600 | 663,700 | 477,400 | 696,400 | -290,300 |